Related Experiment Videos
[DNFB reaction in bladder cancer, an immunological study].
Zeitschrift Fur Urologie Und Nephrologie
|October 1, 1979
Summary
Assessing skin reactivity to dinitrofluorobenzol before treatment can predict tumor spread and prognosis in bladder cancer patients. Immunological tests are crucial for monitoring disease progression alongside clinical evaluations.
Area of Science:
- Oncology
- Immunology
- Dermatology
Background:
- Carcinoma of the urinary bladder is a significant health concern.
- Prognosis and tumor spread are critical factors in patient management.
- Current monitoring relies heavily on clinical examinations.
Purpose of the Study:
- To investigate the prognostic value of epicutaneous skin testing.
- To determine if reactivity to dinitrofluorobenzol correlates with tumor spread.
- To establish the role of immunological assessments in monitoring bladder cancer.
Main Methods:
- Epicutaneous skin testing using dinitrofluorobenzol as the primary antigen.
- Pre-therapy assessment of patient reactivity.
- Correlation analysis between skin test results, tumor spread, and prognosis.
Main Results:
- Pre-therapy dinitrofluorobenzol skin test reactivity serves as a key indicator of tumor spread.
- Skin test results are essential for predicting patient prognosis.
- Immunological examinations provide valuable insights beyond clinical assessments.
Conclusions:
- Epicutaneous skin testing with dinitrofluorobenzol is a valuable tool for assessing bladder cancer.
- Immunological monitoring should be integrated into the routine management of urinary bladder carcinoma.
- This approach enhances the comprehensive evaluation of tumor progression and patient outcomes.